Jones Lang LaSalle Incorporated financials

JLL CIK 0001037976

Source: EDGAR filings · Built 2026-06-04T02:27:25Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
EBITDA 1.35B 1.12B 814.90M 1.10B 1.26B 785.50M
Working Capital 792.80M 334.00M 410.90M 657.60M -98.80M 325.90M
Net Debt 1.23B 1.69B 2.04B 2.16B 1.23B 1.04B
Operating Margin 4.20% 3.70% 2.78% 4.16% 5.39% 3.37%
Net Margin 3.03% 2.33% 1.09% 3.14% 4.97% 2.43%
Return on Equity (ROE) 10.56% 8.07% 3.58% 10.87% 15.55% 7.29%
Return on Assets (ROA) 4.45% 3.26% 1.40% 4.20% 6.20% 2.81%
Current Ratio 1.11× 1.05× 1.06× 1.11× 0.98× 1.05×
Debt-to-Equity 0.24× 0.31× 0.39× 0.45× 0.29× 0.29×
Effective Tax Rate 19.30% 19.51% 10.20% 20.20% 21.60% 20.18%
Cash Conversion Ratio 1.51× 1.44× 2.55× 0.31× 1.01× 2.77×
Accruals Ratio -0.02× -0.01× -0.02× 0.03× -0.00× -0.05×
SBC % of Revenue 0.01% 0.01% 0.02% 0.03% 0.09% 0.22%

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 20.52× 22.40× 40.44× 12.01× 14.58× 19.27×
EV / EBITDA 12.61× 12.18× 13.52× 8.88× 11.66× 10.98×
P/S 0.60× 0.51× 0.43× 0.36× 0.70× 0.46×
P/B 2.11× 1.77× 1.43× 1.26× 2.18× 1.37×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 26.12B 23.43B 20.76B 20.86B 19.37B 16.59B
Operating Expenses 25.02B 22.56B 20.18B 19.99B 18.32B 16.03B
Operating Income (Loss) 1.10B 868.10M 576.50M 868.10M 1.04B 559.10M
Income Tax Expense (Benefit) 189.50M 132.50M 25.70M 200.80M 264.30M 106.90M
Net Income (Loss) Attributable to Parent 792.10M 546.80M 225.40M 654.50M 961.60M 402.50M
Earnings Per Share, Basic $16.73 $11.51 $4.73 $13.51 $18.89 $7.79
Weighted Average Number of Shares Outstanding, Basic 47.35M 47.49M 47.63M 48.45M 50.92M 51.68M
Earnings Per Share, Diluted $16.40 $11.30 $4.67 $13.27 $18.47 $7.70
Weighted Average Number of Shares Outstanding, Diluted 48.31M 48.37M 48.29M 49.34M 52.07M 52.28M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 599.10M 416.30M 410.00M 519.30M 593.70M 574.30M
Assets, Current 8.18B 7.48B 6.86B 6.57B 6.39B 6.45B
Assets 17.80B 16.76B 16.06B 15.59B 15.51B 14.32B
Liabilities, Current 7.39B 7.14B 6.45B 5.91B 6.49B 6.13B
Liabilities 10.18B 9.87B 9.65B 9.44B 9.08B 8.70B
Stockholders' Equity Attributable to Parent 7.50B 6.77B 6.29B 6.02B 6.18B 5.52B
Common Stock, Shares, Outstanding 46.95M 47.42M 47.51M 47.51M 50.02M 51.11M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 1.19B 785.30M 575.80M 199.90M 972.40M 1.11B
Net Cash Provided by (Used in) Investing Activities -336.60M -316.80M -290.40M -243.10M -805.80M -170.60M
Payments for Repurchase of Common Stock 211.50M 80.70M 61.60M 601.20M 343.30M 100.00M
Net Cash Provided by (Used in) Financing Activities -643.20M -451.20M -374.30M -13.10M -143.80M -771.20M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (JLL CIK 0001037976), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ELDN

ELEDON PHARMACEUTICALS, INC.

NRXP

NRX Pharmaceuticals, Inc.

WHD

Cactus, Inc.